Skip Header

 

21 results for author:"van den Berg C."Drop in Literature Citations

Customize display Download...

Page 1 of 1

Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam.

van de Laar T.J., Molenkamp R., van den Berg C., Schinkel J., Beld M.G., Prins M., Coutinho R.A., Bruisten S.M.

J. Hepatol. 51:667-674(2009) · UniProtKB (186)

Two decades of hepatitis B infections among drug users in Amsterdam: are they still a high-risk group?

van Houdt R., van den Berg C.H., Stolte I.G., Bruisten S.M., Dukers N.H., Bakker M., Wolthers K.C., Prins M., Coutinho R.A.

J. Med. Virol. 81:1163-1169(2009) · UniProtKB (65)

Complement factor H binds to denatured rather than to native pentameric C-reactive protein.

Hakobyan S., Harris C.L., van den Berg C.W., Fernandez-Alonso M.C., de Jorge E.G., de Cordoba S.R., Rivas G., Mangione P., Pepys M.B., Morgan B.P.

J. Biol. Chem. 283:30451-30460(2008) · Mapped (7)

Stress and IGF-I differentially control cell fate through mammalian target of rapamycin (mTOR) and retinoblastoma protein (pRB).

Popowski M., Ferguson H.A., Sion A.M., Koller E., Knudsen E., Van Den Berg C.L.

J. Biol. Chem. 283:28265-28273(2008) · Mapped (34)

Loxosceles sphingomyelinase induces complement-dependent dermonecrosis, neutrophil infiltration, and endogenous gelatinase expression.

Tambourgi D.V., Paixao-Cavalcante D., Goncalves-de-Andrade R.M., Fernandes-Pedrosa M.F., Magnoli F.C., Morgan B.P., van den Berg C.W.

J. Invest. Dermatol. 124:725-731(2005) · UniProtKB (1)

Molecular cloning, expression, function and immunoreactivities of members of a gene family of sphingomyelinases from Loxosceles venom glands.

Tambourgi D.V., Fernandes-Pedrosa M.F., Van Den Berg C.W., Goncalves-de-Andrade R.M., Ferracini M., Paixao-Cavalcante D., Morgan B.P., Rushmere N.K.

Mol. Immunol. 41:831-840(2004) · UniProtKB (2)

Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells.

Mingo-Sion A.M., Marietta P.M., Koller E., Wolf D.M., Van Den Berg C.L.

Oncogene 23:596-604(2004) · Mapped (8)

The complete genome sequence of Chromobacterium violaceum reveals remarkable and exploitable bacterial adaptability.

Vasconcelos A.T.R., de Almeida D.F., Hungria M., Guimaraes C.T., Antonio R.V., Almeida F.C., de Almeida L.G.P., de Almeida R., Alves-Gomes J.A., Andrade E.M. et al.

Proc. Natl. Acad. Sci. U.S.A. 100:11660-11665(2003) · UniProtKB (4,400)

UV-induced apoptosis is mediated independent of caspase-9 in MCF-7 cells: a model for cytochrome c resistance.

Ferguson H.A., Marietta P.M., Van Den Berg C.L.

J. Biol. Chem. 278:45793-45800(2003) · Mapped (10)

An inhibitory function for JNK in the regulation of IGF-I signaling in breast cancer.

Mamay C.L., Mingo-Sion A.M., Wolf D.M., Molina M.D., Van Den Berg C.L.

Oncogene 22:602-614(2003) · Mapped (8)

Molecular cloning and expression of a functional dermonecrotic and haemolytic factor from Loxosceles laeta venom.

Fernandes-Pedrosa M.F., Junqueira de Azevedo I.L.M., Goncalves-de-Andrade R.M., van den Berg C.W., Ramos C.R.R., Ho P.L., Tambourgi D.V.

Biochem. Biophys. Res. Commun. 298:638-645(2002) · UniProtKB (3)

Sphingomyelinases in the venom of the spider Loxosceles intermedia are responsible for both dermonecrosis and complement-dependent hemolysis.

Tambourgi D.V., Magnoli F.C., van den Berg C.W., Morgan B.P., de Araujo P.S., Alves E.W., Da Silva W.D.

Biochem. Biophys. Res. Commun. 251:366-373(1998) · UniProtKB (2)

The glycosylation of the complement regulatory protein, human erythrocyte CD59.

Rudd P.M., Morgan B.P., Wormald M.R., Harvey D.J., van den Berg C.W., Davis S.J., Ferguson M.A., Dwek R.A.

J. Biol. Chem. 272:7229-7244(1997) · UniProtKB (1)

Purification and characterization of the pig analogue of human membrane cofactor protein (CD46/MCP).

van den Berg C.W., Perez de la Lastra J.M., Llanes D., Morgan B.P.

J. Immunol. 158:1703-1709(1997) · UniProtKB (1)

Molecular cloning, chromosomal localization, expression, and functional characterization of the mouse analogue of human CD59.

Powell M.B., Marchbank K.J., Rushmere N.K., van den Berg C.W., Morgan B.P.

J. Immunol. 158:1692-1702(1997) · UniProtKB (1) · Mapped (1)

Rapid, activity-guided isolation of sex-limited protein (Slp) from mouse serum by fractionated precipitation and high-performance liquid chromatography.

Van den Berg C.W., Van Dijk H.

J. Immunol. Methods 169:251-256(1994) · Mapped (10)

The sheep analogue of human CD59: purification and characterization of its complement inhibitory activity.

van den Berg C.W., Harrison R.A., Morgan B.P.

Immunology 78:349-357(1993) · UniProtKB (1)

Overexpression of a cellular retinoic acid binding protein (xCRABP) causes anteroposterior defects in developing Xenopus embryos.

Dekker E.J., Vaessen M.J., van den Berg C., Timmermans A., Godsave S., Holling T., Nieuwkoop P., Geurts van Kessel A., Durston A.

Development 120:973-985(1994) · UniProtKB (1)

A rapid method for the isolation of analogues of human CD59 by preparative SDS-PAGE: application to pig CD59.

van den Berg C.W., Harrison R.A., Morgan B.P.

J. Immunol. Methods 179:223-231(1995) · UniProtKB (1)

Molecular cloning of the rat analogue of human CD59: structural comparison with human CD59 and identification of a putative active site.

Rushmere N.K., Harrison R.A., van den Berg C.W., Morgan B.P.

Biochem. J. 304:595-601(1994) · UniProtKB (1)

Slp is an essential component of an EDTA-resistant activation pathway of mouse complement.

van den Berg C.W., Demant P., Aerts P.C., Van Dijk H.

Proc. Natl. Acad. Sci. U.S.A. 89:10711-10715(1992) · Mapped (15)

Page 1 of 1